Rare Disease Spotlight-oncology therapies dominate the orphan drug landscape
The second edition of the Rare Disease Spotlight series investigates the trends in orphan drug designations across therapy areas over almost 40 years.
United States Cell Mediated Immune Monitoring For Research European Union Us National Institutes Of Health Software Solutions For Download Free Report
Source: pharmaceutical-technology.com